Plain-English translation of NCT07413705 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing two medical devices—BTL-699-2 and HPM-6000UF—to see if they can help reduce depression and improve sexual function in women who are perimenopausal or postmenopausal. Some participants will receive the full active treatment, while others will receive a sham (placebo) treatment where the devices are set to very low levels. Over about five months, researchers will measure changes in mood, sexual function, and overall wellbeing.
Many women experience depression and sexual problems during and after menopause, and current treatments don't work for everyone. This trial is exploring whether these two devices together might offer a new, non-medication option to help with these symptoms.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic multiple times over about five months to receive treatment sessions with both devices. Some sessions will include questionnaires about your mood, sexual function, and overall wellbeing. You'll be randomly assigned to either receive the active treatment (full device settings) or sham treatment (very low settings), and you won't know which group you're in. After your final treatment session, you'll have two follow-up visits at one month and three months to see how you're doing.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States
Canada